Nagasawa Masaki
Department of Internal Medicine (Respiratory), Yamagata Prefectural Central Hospital, Japan.
Gan To Kagaku Ryoho. 2011 Oct;38(10):1673-4.
The patient was an 80-year-old man who had an advanced non-small-cell lung cancer with complications such as COPD and dementia. Vinorelbine 20 mg/m(2) was administered intravenously from May 19, 2008. He received 2 doses weekly and rested for a week. He restarted this therapy from July 3, because his dementia was progressing. His therapy was later discontinued, so he was followed up with outpatient observation. During observation, the disease did not progress. In June, 2010, atelectasis and pleural effusion lesions disappeared, according to CT. He was alive in August, 2010.
该患者为一名80岁男性，患有晚期非小细胞肺癌，并伴有慢性阻塞性肺疾病（COPD）和痴呆等并发症。从2008年5月19日起静脉注射长春瑞滨20mg/m²。每周给药2次，休息1周。由于痴呆病情进展，他于7月3日重新开始该治疗。其治疗后来中断，因此对他进行门诊观察随访。在观察期间，病情未进展。根据CT检查，2010年6月，肺不张和胸腔积液病变消失。他在2010年8月仍然存活。
